Cargando…

Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis

OBJECTIVES: Almost all patients with systemic sclerosis (SSc) harbour autoantibodies. Anti-topoisomerase antibodies (ATA) and anti-centromere antibodies (ACA) are most prevalent and associate with distinct clinical phenotypes. B cell responses underlying these phenotypes are ill-defined. To understa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wortel, Corrie M, Liem, Sophie IE, van Leeuwen, Nina M, Boonstra, Maaike, Fehres, Cynthia M, Stöger, Lauran, Huizinga, Tom WJ, Toes, René EM, De Vries-Bouwstra, Jeska, Scherer, Hans U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387632/
https://www.ncbi.nlm.nih.gov/pubmed/37507206
http://dx.doi.org/10.1136/rmdopen-2023-003148
_version_ 1785081926404538368
author Wortel, Corrie M
Liem, Sophie IE
van Leeuwen, Nina M
Boonstra, Maaike
Fehres, Cynthia M
Stöger, Lauran
Huizinga, Tom WJ
Toes, René EM
De Vries-Bouwstra, Jeska
Scherer, Hans U
author_facet Wortel, Corrie M
Liem, Sophie IE
van Leeuwen, Nina M
Boonstra, Maaike
Fehres, Cynthia M
Stöger, Lauran
Huizinga, Tom WJ
Toes, René EM
De Vries-Bouwstra, Jeska
Scherer, Hans U
author_sort Wortel, Corrie M
collection PubMed
description OBJECTIVES: Almost all patients with systemic sclerosis (SSc) harbour autoantibodies. Anti-topoisomerase antibodies (ATA) and anti-centromere antibodies (ACA) are most prevalent and associate with distinct clinical phenotypes. B cell responses underlying these phenotypes are ill-defined. To understand how B cell autoreactivity and disease pathology connect, we determined phenotypic and functional characteristics of autoreactive B cells in ATA-positive and ACA-positive patients. METHODS: Levels and isotypes of autoantibodies secreted by ex vivo cultured peripheral blood mononuclear cells from patients with ATA-positive (n=22) and ACA-positive (n=20) SSc were determined. Antibody secreting cells (ASCs) were isolated by cell sorting and cultured separately. Correlations were studied between the degree of spontaneous autoantibody production and the presence and degree of interstitial lung disease (ILD). RESULTS: Circulating B cells secreting either ATA-immunoglobulin G (IgG) or ACA-IgG on stimulation was readily detectable in patients. The ATA response, but not the ACA response, showed additional secretion of autoreactive IgA. ATA-IgG and ATA-IgA were also secreted spontaneously. Additional cell sorting confirmed the presence of ATA-secreting plasmablasts. The degree of spontaneous ATA-secretion was higher in patients with ILD than in those without (p<0.001) and correlated with the degree of pulmonary fibrosis (p<0.001). CONCLUSION: In contrast to ACA-positive patients, ATA-positive patients show signs of recent activation of the B cell response that hallmarks this disease. The degree of activation correlates with the presence and severity of ILD, the most deleterious disease manifestation. This could explain differential responsiveness to B cell depleting therapy. The abundant and spontaneous secretion of ATA-IgG and ATA-IgA may point toward a continuously activating trigger.
format Online
Article
Text
id pubmed-10387632
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-103876322023-08-01 Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis Wortel, Corrie M Liem, Sophie IE van Leeuwen, Nina M Boonstra, Maaike Fehres, Cynthia M Stöger, Lauran Huizinga, Tom WJ Toes, René EM De Vries-Bouwstra, Jeska Scherer, Hans U RMD Open Systemic Sclerosis OBJECTIVES: Almost all patients with systemic sclerosis (SSc) harbour autoantibodies. Anti-topoisomerase antibodies (ATA) and anti-centromere antibodies (ACA) are most prevalent and associate with distinct clinical phenotypes. B cell responses underlying these phenotypes are ill-defined. To understand how B cell autoreactivity and disease pathology connect, we determined phenotypic and functional characteristics of autoreactive B cells in ATA-positive and ACA-positive patients. METHODS: Levels and isotypes of autoantibodies secreted by ex vivo cultured peripheral blood mononuclear cells from patients with ATA-positive (n=22) and ACA-positive (n=20) SSc were determined. Antibody secreting cells (ASCs) were isolated by cell sorting and cultured separately. Correlations were studied between the degree of spontaneous autoantibody production and the presence and degree of interstitial lung disease (ILD). RESULTS: Circulating B cells secreting either ATA-immunoglobulin G (IgG) or ACA-IgG on stimulation was readily detectable in patients. The ATA response, but not the ACA response, showed additional secretion of autoreactive IgA. ATA-IgG and ATA-IgA were also secreted spontaneously. Additional cell sorting confirmed the presence of ATA-secreting plasmablasts. The degree of spontaneous ATA-secretion was higher in patients with ILD than in those without (p<0.001) and correlated with the degree of pulmonary fibrosis (p<0.001). CONCLUSION: In contrast to ACA-positive patients, ATA-positive patients show signs of recent activation of the B cell response that hallmarks this disease. The degree of activation correlates with the presence and severity of ILD, the most deleterious disease manifestation. This could explain differential responsiveness to B cell depleting therapy. The abundant and spontaneous secretion of ATA-IgG and ATA-IgA may point toward a continuously activating trigger. BMJ Publishing Group 2023-07-28 /pmc/articles/PMC10387632/ /pubmed/37507206 http://dx.doi.org/10.1136/rmdopen-2023-003148 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Systemic Sclerosis
Wortel, Corrie M
Liem, Sophie IE
van Leeuwen, Nina M
Boonstra, Maaike
Fehres, Cynthia M
Stöger, Lauran
Huizinga, Tom WJ
Toes, René EM
De Vries-Bouwstra, Jeska
Scherer, Hans U
Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis
title Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis
title_full Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis
title_fullStr Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis
title_full_unstemmed Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis
title_short Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis
title_sort anti-topoisomerase, but not anti-centromere b cell responses in systemic sclerosis display active, ig-secreting cells associated with lung fibrosis
topic Systemic Sclerosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387632/
https://www.ncbi.nlm.nih.gov/pubmed/37507206
http://dx.doi.org/10.1136/rmdopen-2023-003148
work_keys_str_mv AT wortelcorriem antitopoisomerasebutnotanticentromerebcellresponsesinsystemicsclerosisdisplayactiveigsecretingcellsassociatedwithlungfibrosis
AT liemsophieie antitopoisomerasebutnotanticentromerebcellresponsesinsystemicsclerosisdisplayactiveigsecretingcellsassociatedwithlungfibrosis
AT vanleeuwenninam antitopoisomerasebutnotanticentromerebcellresponsesinsystemicsclerosisdisplayactiveigsecretingcellsassociatedwithlungfibrosis
AT boonstramaaike antitopoisomerasebutnotanticentromerebcellresponsesinsystemicsclerosisdisplayactiveigsecretingcellsassociatedwithlungfibrosis
AT fehrescynthiam antitopoisomerasebutnotanticentromerebcellresponsesinsystemicsclerosisdisplayactiveigsecretingcellsassociatedwithlungfibrosis
AT stogerlauran antitopoisomerasebutnotanticentromerebcellresponsesinsystemicsclerosisdisplayactiveigsecretingcellsassociatedwithlungfibrosis
AT huizingatomwj antitopoisomerasebutnotanticentromerebcellresponsesinsystemicsclerosisdisplayactiveigsecretingcellsassociatedwithlungfibrosis
AT toesreneem antitopoisomerasebutnotanticentromerebcellresponsesinsystemicsclerosisdisplayactiveigsecretingcellsassociatedwithlungfibrosis
AT devriesbouwstrajeska antitopoisomerasebutnotanticentromerebcellresponsesinsystemicsclerosisdisplayactiveigsecretingcellsassociatedwithlungfibrosis
AT schererhansu antitopoisomerasebutnotanticentromerebcellresponsesinsystemicsclerosisdisplayactiveigsecretingcellsassociatedwithlungfibrosis